Erratum: S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE) (PLoS ONE (2011) 6:4 (e19375) DOI: 10.1371/journal.pone.0019375);S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Jin, Qing'e ^a   Chen, Hongyan ^a   Luo, Aiping ^a   Ding, Fang ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CASPASE 3; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN S 100; PROTEIN S 100A14; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; S100A14 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE ACTIVATION; GENE CONSTRUCT; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; PROTEIN CARBOHYDRATE INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; CHEMISTRY; DOMINANT GENE; GENE EXPRESSION REGULATION; METABOLISM; MUTATION; PROTEIN BINDING; TUMOR CELL LINE;

APOPTOSIS; CALCIUM-BINDING PROTEINS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; MAP KINASE SIGNALING SYSTEM; MUTATION; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 79955751670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147881     Document Type: Erratum

References (46)

1. Donato R, (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540-551.
2. Donato R, (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668.
3. Donato R, (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7: 711-724.
4. Emberley ED, Murphy LC, Watson PH, (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82: 508-515.
5. Heizmann CW, Ackermann GE, Galichet A, (2007) Pathologies involving the S100 proteins and RAGE. Subcell Biochem 45: 93-138.
6. Hsieh HL, Schafer BW, Weigle B, Heizmann CW, (2004) S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun 316: 949-959.
7. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, et al. (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7: 1479-1499.
8. Salama I, Malone PS, Mihaimeed F, Jones JL, (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364.
9. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, et al. (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83: 876-886.
10. Logsdon CD, Fuentes MK, Huang EH, Arumugam T, (2007) RAGE and RAGE ligands in cancer. Curr Mol Med 7: 777-789.
11. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360.
12. Huttunen HJ, Fages C, Rauvala H, (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274: 19919-19924.
13. Leclerc E, Fritz G, Vetter SW, Heizmann CW, (2009) Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793: 993-1007.
14. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A, (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282: 31317-31331.
15. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D, (2006) S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312: 184-197.
16. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, et al. (2008) S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83: 1484-1492.
17. Sorci G, Riuzzi F, Agneletti AL, Marchetti C, Donato R, (2004) S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner. J Cell Physiol 199: 274-283.
18. Sorci G, Riuzzi F, Agneletti AL, Marchetti C, Donato R, (2003) S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol 23: 4870-4881.
19. Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, et al. (2008) S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta 1783: 297-311.
20. Pietas A, Schluns K, Marenholz I, Schafer BW, Heizmann CW, et al. (2002) Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 79: 513-522.
21. Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, et al. (2010) Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep 23: 45-52.
22. Lavoie C, Meerloo T, Lin P, Farquhar MG, (2002) Calnuc, an EF-hand Ca(2+)-binding protein, is stored and processed in the Golgi and secreted by the constitutive-like pathway in AtT20 cells. Mol Endocrinol 16: 2462-2474.
23. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, et al. (2003) Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 278: 6482-6489.
24. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, et al. (2007) Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 27: 3051-3058.
25. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, et al. (2005) Global gene expression profiling of circulating tumor cells. Cancer Res 65: 4993-4997.
26. Chen H, Yu D, Luo A, Tan W, Zhang C, et al. (2009) Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res 69: 3451-3457.
27. Schmidt-Hansen B, Klingelhofer J, Grum-Schwensen B, Christensen A, Andresen S, et al. (2004) Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J Biol Chem 279: 24498-24504.
28. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H, (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62: 4805-4811.
29. Ghavami S, Kerkhoff C, Los M, Hashemi M, Sorg C, et al. (2004) Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukoc Biol 76: 169-175.
30. Fleury C, Mignotte B, Vayssiere JL, (2002) Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84: 131-141.
31. Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, et al. (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148: 548-558.
32. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
33. Yammani RR, Carlson CS, Bresnick AR, Loeser RF, (2006) Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. Arthritis Rheum 54: 2901-2911.
34. Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, et al. (2005) Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 175: 8296-8302.
35. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD, (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279: 5059-5065.
36. Fuentes MK, Nigavekar SS, Arumugam T, Logsdon CD, Schmidt AM, et al. (2007) RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 2621 50: 1230-1240.
37. Arumugam T, Simeone DM, Van Golen K, Logsdon CD, (2005) S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11: 5356-5364.
38. Rincon M, Davis RJ, (2009) Regulation of the immune response by stress-activated protein kinases. Immunol Rev 228: 212-224.
39. Zhang S, Wang G, Liu D, Bao Z, Fernig DG, et al. (2005) The C-terminal region of S100A4 is important for its metastasis-inducing properties. Oncogene 24: 4401-4411.
40. Ismail TM, Zhang S, Fernig DG, Gross S, Martin-Fernandez ML, et al. (2010) Self-association of calcium-binding protein S100A4 and metastasis. J Biol Chem 285: 914-922.
41. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, et al. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275: 40096-40105.
42. Businaro R, Leone S, Fabrizi C, Sorci G, Donato R, et al. (2006) S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res 83: 897-906.
43. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T, (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284.
44. Han Y, Wei F, Xu X, Cai Y, Chen B, et al. (2002) [Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19: 455-457.
45. Luo A, Kong J, Hu G, Liew CC, Xiong M, et al. (2004) Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299.
46. Zhang L, Ding F, Cao W, Liu Z, Liu W, et al. (2006) Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res 12: 1639-1646.